Effect of PAF-acether antagonists on active anaphylactic mouse paw edema
- PMID: 1668123
- DOI: 10.1007/BF02536574
Effect of PAF-acether antagonists on active anaphylactic mouse paw edema
Abstract
A new model of active anaphylactic reaction in mice was developed. The edematogenic reaction appeared 5 min after the intraplantar injection of ovalbumin, peaked at 30 min after the antigenic challenge, and decreased thereafter. Using the non-steroidal, anti-inflammatory agents indomethacin and aspirin, we found that cyclooxygenase products do not participate in the reaction. In contrast, vasoactive amines appear to be involved, because meclizine and methysergide reduced the edema. Dexamethasone, BW755C, LY 171883 and WEB 2170 effectively interfered with the edematogenic reaction, which suggests that lipid mediators such as leukotrienes and PAF play a role in the active anaphylactic response.
Similar articles
-
Involvement of PAF-acether in the anaphylactic shock in the rat.J Lipid Mediat. 1989 May-Jun;1(3):161-70. J Lipid Mediat. 1989. PMID: 2519891
-
The pharmacological profile of mouse hind paw inflammation induced by staphylococcal enterotoxin type A.Inflamm Res. 1997 Sep;46(9):361-5. doi: 10.1007/s000110050202. Inflamm Res. 1997. PMID: 9339392
-
Inhibition by WEB 2086, a PAG-acether antagonist of oedema and peritonitis induced by zymosan in rats.Arch Int Pharmacodyn Ther. 1990 Jul-Aug;306:161-9. Arch Int Pharmacodyn Ther. 1990. PMID: 2076045
-
New trends in PAF antagonist research: a new series of potent hetrapazine-derived PAF antagonists.Agents Actions. 1991 Jan;32(1-2):34-6. doi: 10.1007/BF01983304. Agents Actions. 1991. PMID: 2058466 Review. No abstract available.
-
PAF-acether today--relevance for acute experimental anaphylaxis.Br Med Bull. 1987 Apr;43(2):312-35. doi: 10.1093/oxfordjournals.bmb.a072185. Br Med Bull. 1987. PMID: 2825900 Review. No abstract available.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical